Immunoproteasomes: regulating the regulator.
作者信息
Yewdell Jonathan W
机构信息
Cellular Biology Section, Laboratory of Viral Diseases, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-0440, USA.
出版信息
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9089-90. doi: 10.1073/pnas.0504018102. Epub 2005 Jun 20.
Abstract
摘要
相似文献
1
Immunoproteasomes: regulating the regulator.免疫蛋白酶体：调控调节因子
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9089-90. doi: 10.1073/pnas.0504018102. Epub 2005 Jun 20.
2
IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response.干扰素-γ诱导的蛋白酶体系统免疫适应性是一种加速的短暂反应。
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9241-6. doi: 10.1073/pnas.0501711102. Epub 2005 Jun 8.
3
[Structure, function and structural organization of proteasome].
Tanpakushitsu Kakusan Koso. 2005 Aug;50(10 Suppl):1189-96.
4
Immunoproteasomes at the interface of innate and adaptive immune responses: two faces of one enzyme.免疫蛋白酶体在先天免疫和适应性免疫反应的界面：一种酶的两面。
Curr Opin Immunol. 2012 Feb;24(1):77-83. doi: 10.1016/j.coi.2012.01.005. Epub 2012 Jan 31.
5
N-terminal-prolonged vinyl ester-based peptides as selective proteasome beta1 subunit inhibitors.基于N端延长的乙烯基酯的肽作为选择性蛋白酶体β1亚基抑制剂。
Bioorg Med Chem. 2009 Aug 1;17(15):5535-40. doi: 10.1016/j.bmc.2009.06.025. Epub 2009 Jun 18.
6
PCI complexes: Beyond the proteasome, CSN, and eIF3 Troika.PCI复合物：超越蛋白酶体、COP9信号体和真核翻译起始因子3三元复合体。
Mol Cell. 2009 Aug 14;35(3):260-4. doi: 10.1016/j.molcel.2009.07.009.
7
The ubiquitin-interacting motif of 26S proteasome subunit S5a induces A549 lung cancer cell death.26S蛋白酶体亚基S5a的泛素相互作用基序诱导A549肺癌细胞死亡。
Biochem Biophys Res Commun. 2007 Dec 14;364(2):226-30. doi: 10.1016/j.bbrc.2007.09.127. Epub 2007 Oct 11.
8
IAPs--the ubiquitin connection.凋亡抑制蛋白——泛素连接
Cell Death Differ. 2005 Sep;12(9):1205-7. doi: 10.1038/sj.cdd.4401696.
9
The role of ubiquitin-proteasome system in ageing.泛素-蛋白酶体系统在衰老中的作用。
Gen Comp Endocrinol. 2011 May 15;172(1):39-43. doi: 10.1016/j.ygcen.2011.02.005. Epub 2011 Feb 13.
10
[Structural biology of proteasome].[蛋白酶体的结构生物学]
Tanpakushitsu Kakusan Koso. 2006 Aug;51(10 Suppl):1219-23.
引用本文的文献
1
Immunoproteasome Activation Expands the MHC Class I Immunopeptidome, Unmasks Neoantigens, and Enhances T-cell Anti-Myeloma Activity.免疫蛋白酶体激活可扩展MHC I类免疫肽组，揭示新抗原，并增强T细胞抗骨髓瘤活性。
Mol Cancer Ther. 2024 Dec 3;23(12):1743-1760. doi: 10.1158/1535-7163.MCT-23-0931.
2
Genetics of IgA nephrology: risks, mechanisms, and therapeutic targets.IgA 肾病的遗传学：风险、机制和治疗靶点。
Pediatr Nephrol. 2024 Nov;39(11):3157-3165. doi: 10.1007/s00467-024-06369-7. Epub 2024 Apr 11.
3
Identification of a new class of proteasome inhibitors based on a naphthyl-azotricyclic-urea-phenyl scaffold.基于萘基-氮杂三环-脲-苯基支架鉴定一类新型蛋白酶体抑制剂。
RSC Med Chem. 2023 Feb 6;14(3):573-582. doi: 10.1039/d2md00404f. eCollection 2023 Mar 22.
4
HIV-1 Nef Interacts with LMP7 To Attenuate Immunoproteasome Formation and Major Histocompatibility Complex Class I Antigen Presentation.HIV-1 Nef 与 LMP7 相互作用以减弱免疫蛋白酶体的形成和主要组织相容性复合体 I 类抗原呈递。
mBio. 2020 Oct 27;11(5):e02221-19. doi: 10.1128/mBio.02221-19.
5
Adaptation of Proteasomes and Lysosomes to Cellular Environments.蛋白酶体和溶酶体对细胞环境的适应。
Cells. 2020 Oct 1;9(10):2221. doi: 10.3390/cells9102221.
6
Cellular Responses to Proteasome Inhibition: Molecular Mechanisms and Beyond.细胞对蛋白酶体抑制的反应：分子机制及其他。
Int J Mol Sci. 2019 Jul 10;20(14):3379. doi: 10.3390/ijms20143379.
7
Ubiquitin-Proteasome System in Neurodegenerative Disorders.神经退行性疾病中的泛素-蛋白酶体系统
J Drug Metab Toxicol. 2015;6(4). doi: 10.4172/2157-7609.1000187. Epub 2015 Aug 13.
8
Origin and evolution of the specialized forms of proteasomes involved in antigen presentation.参与抗原呈递的蛋白酶体特殊形式的起源和进化。
Immunogenetics. 2019 Mar;71(3):251-261. doi: 10.1007/s00251-019-01105-0. Epub 2019 Jan 24.
9
A Marine Diterpenoid Modulates the Proteasome Activity in Murine Macrophages Stimulated with LPS.一种海洋二萜类化合物可调节 LPS 刺激的小鼠巨噬细胞中的蛋白酶体活性。
Biomolecules. 2018 Oct 5;8(4):109. doi: 10.3390/biom8040109.
10
Islet stress, degradation and autoimmunity.胰岛应激、降解和自身免疫。
Diabetes Obes Metab. 2018 Sep;20 Suppl 2(Suppl Suppl 2):88-94. doi: 10.1111/dom.13387.
本文引用的文献
1
IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response.干扰素-γ诱导的蛋白酶体系统免疫适应性是一种加速的短暂反应。
Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9241-6. doi: 10.1073/pnas.0501711102. Epub 2005 Jun 8.
2
Protein-protein interactions among human 20S proteasome subunits and proteassemblin.人类20S蛋白酶体亚基与蛋白酶体装配素之间的蛋白质-蛋白质相互作用。
Biochem Biophys Res Commun. 2004 Feb 6;314(2):523-8. doi: 10.1016/j.bbrc.2003.12.119.
3
Making sense of mass destruction: quantitating MHC class I antigen presentation.理解大规模杀伤：定量MHC I类抗原呈递。
Nat Rev Immunol. 2003 Dec;3(12):952-61. doi: 10.1038/nri1250.
4
Ubiquitin-independent proteolytic functions of the proteasome.蛋白酶体的非泛素依赖性蛋白水解功能。
Arch Biochem Biophys. 2003 Jul 1;415(1):1-5. doi: 10.1016/s0003-9861(03)00197-8.
5
Immunoproteasome expression in a nonimmune tissue, the ocular lens.
Arch Biochem Biophys. 2002 Sep 15;405(2):147-53. doi: 10.1016/s0003-9861(02)00341-7.
6
The structure of the mammalian 20S proteasome at 2.75 A resolution.分辨率为2.75埃的哺乳动物20S蛋白酶体结构。
Structure. 2002 May;10(5):609-18. doi: 10.1016/s0969-2126(02)00748-7.
7
Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver.在肝脏的抗病毒和抗菌免疫反应过程中，免疫蛋白酶体在很大程度上取代了组成型蛋白酶体。
J Immunol. 2001 Dec 15;167(12):6859-68. doi: 10.4049/jimmunol.167.12.6859.
8
Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens.免疫蛋白酶体在T细胞库和病毒抗原呈递水平上塑造抗病毒CD8(+) T细胞的免疫显性层次结构。
J Exp Med. 2001 Jun 4;193(11):1319-26. doi: 10.1084/jem.193.11.1319.
9
Mechanisms of intracellular protein breakdown.细胞内蛋白质降解的机制。
Annu Rev Biochem. 1982;51:335-64. doi: 10.1146/annurev.bi.51.070182.002003.
10
Control of enzyme levels in mammalian tissues.哺乳动物组织中酶水平的调控。
Adv Enzymol Relat Areas Mol Biol. 1973;37:135-87. doi: 10.1002/9780470122822.ch3.
Zotero 插件